Ossu - Company finances
|
EUR
|
2021
From: 2021-09-17
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | 0 | 0 | 2,909 | 6,416 | 6,233 |
| Profit before tax | 0 | -1,196 | 1,415 | 3,426 | 3,299 |
| Net profit | 0 | -1,196 | 1,373 | 3,255 | 3,101 |
| Equity | 0 | 4 | 1,125 | 4,381 | 7,441 |
| Liabilities | 0 | 0 | 1,423 | 377 | 477 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 |
| Current assets | 0 | 4 | 2,548 | 4,758 | 7,918 |
| Total assets | 0 | 4 | 2,548 | 4,758 | 7,918 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 392 | 140 | 171 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | - | +120.6% | -2.9% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | -29900.0% | 53.9% | 68.4% | 39.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | -29900.0% | 122.0% | 74.3% | 41.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | 47.2% | 50.7% | 49.8% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | 48.6% | 53.4% | 52.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 1.3 | 0.1 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Ossu - Social security debts
The company had no debts to Sodra
Ossu - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Ossu is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-07-01 | 2026-09-02 | 0.2 |
| 2026-03-27 | 2026-06-05 | 1.8 |
| 2026-03-20 | 2026-03-26 | 3.6 |
| 2025-08-01 | 2026-03-19 | 1.8 |
| 2025-07-31 | 2025-07-31 | 0.7 |
| 2025-07-19 | 2025-07-22 | 171.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Ossu, MB (code 305901126) is a Small partnership engaged in the retail sale of pharmaceutical products. In the latest financial year, 2025, the company generated revenue of €6.2K and net profit of €3.1K, keeping profitability close to one half of sales. Revenue declined slightly by 2.9% year on year, after rising from €2.9K in 2023 to €6.4K in 2024, so the two-year trend remains strongly positive. Profit followed a similar path, increasing from €1.4K in 2023 to €3.3K in 2024 and then easing marginally to €3.1K in 2025. The balance sheet strengthened further in 2025: total assets reached €7.9K, equity €7.4K and liabilities €477. The equity ratio stood at 94.0%, while debt remained low with a debt-to-equity ratio of 0.06. Asset turnover was 0.79x, indicating modest revenue generation relative to the asset base. Return indicators remained strong, supported by the company’s high profitability and limited leverage.